Natural Product (NP) Details
General Information of the NP (ID: NP0075) | |||||
---|---|---|---|---|---|
Name |
Xylitol
|
||||
Synonyms |
xylitol; ribitol; adonitol; 87-99-0; Xylite; 488-81-3; D-Xylitol; Adonite; Adonit; D-ribitol; Eutrit; Klinit; Xyliton; Xylit; Xylite (sugar); Kannit; Newtol; 1,2,3,4,5-pentanepentol; Xylisorb; L-ribitol; (2R,3R,4S)-Pentane-1,2,3,4,5-pentaol; (2R,3S,4S)-Pentane-1,2,3,4,5-pentaol; meso-ribitol; meso-xylitol; L-xylitol; D-Adonitol; UNII-353ZQ9TVDA; UNII-VCQ006KQ1E; NSC 25283; BRN 1720523; CHEBI:15963; CHEBI:17151; (2S,4R)-pentane-1,2,3,4,5-pentol; 1,2,3,4,5-Pentahydroxypentane; (2R,3s,4S)-pentane-1,2,3,4,5-pentol; MFCD00064291; MFCD00064292; 353ZQ9TVDA; VCQ006KQ1E; Xylooligosaccharide; Adonitol, 99+%; Xylitol, 99+%; (2R,3r,4S)-pentane-1,2,3,4,5-pentol; 4-01-00-02832 (Beilstein Handbook Reference); C5H12O5; EINECS 201-788-0; Adonito; Fluorette; Kylit; xylo-Pentitol; Xylitol [INN:BAN:JAN:NF]; NSC-25283; DL-Arabinit; Xylitol C; HSDB 7967; Xylitab DC; Wood sugar alcohol; RB0; Xylitol,(S); EINECS 207-685-7; Ribitol (Adonitol); Adonitol (7CI); Xylisorb 300; Xylisorb 700; NSC 16868; Xylitab 100; Xylitab 300; BRN 1720524; D-ribitol (incorrect); L-ribitol (incorrect); Adonitol, >=99%; (2R,4S)-pentane-1,2,3,4,5-pentol; Xylitol, >=99%; bmse000062; bmse000129; bmse000886; Epitope ID:114702; Epitope ID:114703; EC 201-788-0; SCHEMBL4250; Xylitol, analytical standard; DSSTox_CID_22514; DSSTox_RID_80046; DSSTox_GSID_42514; SCHEMBL15318; MLS002695898; CHEMBL96783; Ribitol (6CI,8CI,9CI); INS NO.967; QSPL 191; SCHEMBL1924966; CHEMBL1865120; CHEMBL3137744; DTXSID7042514; INS-967; HY-N0538; Tox21_201056; s2612; s4546; ZINC18068098; AKOS015903403; AKOS015915193; ZINC100014205; ZINC100018612; CCG-214167; CCG-266218; CS-6043; DB01904; DB11195; DB14704; CAS-87-99-0; (2S,4R)pentane-1,2,3,4,5-pentaol; NCGC00165982-01; NCGC00165982-02; NCGC00258609-01; NCGC00390798-01; Adonitol, BioXtra, >=99.0% (HPLC); AS-55964; DS-11416; E967; K573; SMR001562099; HY-100582; Xylitol, Vetec(TM) reagent grade, >=99%; A0171; E-967; N1725; ST50411707; SW220290-1; Xylite 1000 microg/mL in Acetonitrile:Water; 2088-EP2272822A1; 2088-EP2275417A2; 2088-EP2284162A2; 2088-EP2284163A2; 2088-EP2292234A1; 2088-EP2292612A2; 2088-EP2301938A1; 2088-EP2305254A1; 2088-EP2311842A2; 2088-EP2314584A1; 2088-EP2371811A2; 2088-EP2377849A2; Adonitol, BioReagent, suitable for cell culture; C00379; C00474; K-9195; X-7000; WURCS=2.0/1,1,0/[h212h]/1/; WURCS=2.0/1,1,0/[h222h]/1/; 127873-EP2275398A1; 127873-EP2295402A2; 127873-EP2374783A1; 127873-EP2377841A1; Q212093; Q416534; (S)-1-BOC-2-METHYLSULFONYLETHYL-PIPERAZINE; Xylitol, European Pharmacopoeia (EP) Reference Standard; UNII-YFV05Y57M9 component HEBKCHPVOIAQTA-SCDXWVJYSA-N; UNII-YFV05Y57M9 component HEBKCHPVOIAQTA-ZXFHETKHSA-N; 5DCF4F57-E023-469A-B4F3-91E8349A6705; Xylitol, United States Pharmacopeia (USP) Reference Standard; 6684F574-C267-40CB-8828-12F2550E58D0; Xylitol, Pharmaceutical Secondary Standard; Certified Reference Material
Click to Show/Hide
|
||||
Species Origin | Saccharomyces cerevisiae ... | Click to Show/Hide | |||
Saccharomyces cerevisiae | |||||
Disease | Food additive [ICD-11: N.A.] | Approved | [1] | ||
Structure |
![]() |
Click to Download Mol2D MOL |
|||
Click to Show/Hide the Molecular Information and External Link(s) of This Natural Product | |||||
Formula |
C5H12O5
|
||||
PubChem CID | |||||
Canonical SMILES |
C(C(C(C(CO)O)O)O)O
|
||||
InChI |
1S/C5H12O5/c6-1-3(8)5(10)4(9)2-7/h3-10H,1-2H2/t3-,4+,5?
|
||||
InChIKey |
HEBKCHPVOIAQTA-NGQZWQHPSA-N
|
||||
CAS Number |
CAS 87-99-0
|
||||
ChEBI ID | |||||
Herb ID | |||||
SymMap ID | |||||
TCMSP ID |
Combinatorial Therapeutic Effect(s) Validated Clinically or Experimentally | ||||||
---|---|---|---|---|---|---|
α. A List of Drug(s) Whose Efficacy can be Enhanced by This NP | ||||||
Chlorhexidine | Bacterial infection | Click to Show/Hide the Molecular Data of This Drug | ||||
Achieving Therapeutic Synergy | Click to Show/Hide | |||||
Representative Experiment Reporting the Effect of This Combination | [2] | |||||
Detail(s) |
Combination Info
![]() |
|||||
Experimental
Result(s) |
The XYL + CHX combination was efficient and superior to single treatments in controlling biofilm and suppressing S. mutans. | |||||
Sucrose | Pain | Click to Show/Hide the Molecular Data of This Drug | ||||
Achieving Therapeutic Synergy | Click to Show/Hide | |||||
Representative Experiment Reporting the Effect of This Combination | [3] | |||||
Detail(s) |
Combination Info
![]() |
|||||
In-vivo Model | Obsborne-Mendel rats were inoculated once with a heavy suspension of S. mutans 50B4, serotype d, of human origin. | |||||
Experimental
Result(s) |
This study confirms the suggested therapeutic effect of xylitol even when mixed with sucrose, while nonspecific effects were eliminated. |
